Cargando…
Myeloid-derived suppressor cells: Cellular missiles to target tumors
While conventional anticancer therapies, including surgical resection, radiotherapy, and/or chemotherapy, are relatively efficient at eliminating primary tumors, these treatment modalities are largely ineffective against metastases. At least in part, this reflects the rather inefficient delivery of...
Autores principales: | Chandra, Dinesh, Gravekamp, Claudia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Landes Bioscience
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3890360/ https://www.ncbi.nlm.nih.gov/pubmed/24427545 http://dx.doi.org/10.4161/onci.26967 |
Ejemplares similares
-
Myeloid-Derived Suppressor Cells in Solid Tumors
por: Ma, Tianmiao, et al.
Publicado: (2022) -
Myeloid derived suppressor cells: Targets for therapy
por: Waldron, Todd J., et al.
Publicado: (2013) -
Tumor buster - where will the CAR-T cell therapy ‘missile’ go?
por: Qu, Chunrun, et al.
Publicado: (2022) -
Myeloid-derived suppressor cells have a central role in attenuated Listeria monocytogenes-based immunotherapy against metastatic breast cancer in young and old mice
por: Chandra, D, et al.
Publicado: (2013) -
Drug conjugates for targeting regulatory T cells in the tumor microenvironment: guided missiles for cancer treatment
por: Yang, Juwon, et al.
Publicado: (2023)